8. } [主訴 Chief Complaint]:
- "This is the worst pain I have ever felt in my life.“
主訴一定是以病人的口吻描述,通常描述的症狀/病徵,或就
診原因
} [最近病史 HPI]:
- Gary Roberts is a 68-year-old man admitted to the
ED complaining of chest pressure/pain lasting 20~30
minutes occurring at rest. He describes the pain as
substernal, crushing, and pressurelike that radiates
病例報告 - CC & HPI
8
Note
9. } [最近病史 HPI]:
to his jaw and is accompanied by nausea and
diaphoresis. The pain first started approximately 6
hours ago after he ate breakfast and was unrelieved
by antacids or SL NTG x 3. He also states he has
been experiencing intermittent chest pain over the
past 3~4 weeks with minimal exertion.
最近病史描述的是與本次就診有關的故事,會進一步描述主
訴,包括症狀、發生時間、相關處置等等
病例報告 - HPI
9
Note
10. } [過去病史 PMH]:
- HTN
- Type 2 DM
- Dyslipidemia
- CAD with PCI with a bare metal stent 10 years ago
過去病史最好包括疾病、嚴重度/分期、曾經接受的治療 及
治療反應 (是否達治療目標),例如:
“Chronic kidney disease (Stage VI): eGFR 18 ml/min/
1.73 m2 two weeks ago.”
病例報告 - PMH
10
Note
11. } [家族史 FH]:
- Father died from heart failure at age 75 and mother
is alive at age 88 with HTN and type 2 DM.
家族史並非族譜,僅需描述與疾病相關之家族成員狀況即
可,以直系血親為主 (感染性疾病除外)
} [社交史 SH]:
- (+) Tobacco x 20 years but quit when he received his
BMS 10 years ago; drinks beer usually on weekends;
denies illicit drug use.
病例報告 - FH
11
Note
社交史描述的重點是生活型態
12. } [家族史 FH]: 家族樹 (family tree) 通常沒什麼幫助!
請記錄與「健康」有關的事項,其他的…就…
病例報告 - FH
12
冠狀動脈血管疾病掛了!
I
II
III
Coronary artery disease
Traffic accident
男的
女的
Note 車禍也掛了~
13. } [用藥史 Meds]:
- Aspirin 81 mg po daily
- Metoprolol tartrate 25 mg po BID
- Simvastatin 40 mg po QHS
- Metformin 500 mg po BID
- SL NTG PRN CP
} [過敏史 All]: NKDA (no know drug allergy)
用藥史/過敏史必須詳盡,用藥史最好包括遵醫囑性,過敏史
最好包括症狀甚至是再暴露反應,這些都是連續性照護重點
病例報告 - 用藥史
13
用藥史應包括藥名、劑量、頻次、用法
Note
14. } [系統總覽 ROS]:
- Positive for some baseline CP on exertion for the
past 3~4 weeks, now with CP at rest
} [理學檢查 PE]:
- Gen: WDWN man, A & O x 3, still with ongoing chest
pain, somewhat anxious
- VS: BP 145/92, P 89, RR 18, T 37.1; Wt 95 kg, Ht
170 cm
- HEENT: PERRLA, EOMI, fundi benign; TMs intact
- Neck: No bruits; mild JVD; no thyromegaly
病例報告 - ROS & PE
14
系統總覽描述的是醫療人員對病人的「印象」
15. } [理學檢查 PE]:
- Lungs: Few dependent inspiratory crackles; bi-
basilar rales; no wheezes
- CV: Normal S1 and S2, no MRG
- Abd: Soft, nontender; liver span 10~12 cm; no bruits
- Genit/Rect: Deferred
- MS/Ext: Normal ROM; muscle strength on right 5/5
UE/LE; on left 4/5 UE/LE; pulses 2+; no femoral
bruits or peripheral edema
- Neuro: CNs II–XII intact; DTRs decreased on left;
negative Babinski's sign
病例報告 - PE
15
22. } [問題 Questions]:
- Problem identification
- Which findings in this patient's case history are
consistent with acute STEMI?
- What risk factors for the development of coronary
artery disease are present in this patient?
這些問題多著重於讓同學們練習擷取並整理相關資訊,並進
一步抽絲剝繭列出危險因子;最好能根據症狀 (symptom)/
病徵 (sign) 等線索排列;症狀通常是主觀的,而病徵通常是
客觀的
病例問題 – 病例內容
22
練習將病例資訊與疾病相呼應
判斷與疾病有關之危險因子Note
23. 怎麼寫「SOAP」?
} 病歷閱讀/SOAP繕寫
- S-O-A-P是一種「思考」,不是一種「表格」
常見錯誤: 寫 (抄) 的跟醫師一樣 (把診斷當作評估)、沒有問
題為導向 (不知道自己在寫什麼)
醫師版 藥師版
S (主觀) 病患主觀描述、外觀/症狀 同
O (客觀) 病患病史、檢查結果,實驗
室與相關檢查
同,更著重用藥史
A (評估) 診斷或臆測疾病 評估藥物相關問題
P (計畫) 治療或診斷 (疾病) 計畫 治療或診斷 (藥物不良
反應) 計畫
我跟你寫得不太一樣喔!!
Note
23
24. } [參考答案 Answers]:
- Symptoms: A substernal, crushing, and pressure-
like chest pain that radiates to his jaw and is
accompanied by nausea and diaphoresis occurring
at rest
- Signs: High troponin I level, abnormal ECG findings
(ST-segment elevation in inferior leads, and right
bundle branches block)
建議可參考疾病診斷標準作答,參考資料包括教科書與疾病
診斷/治療指引 (不要只抄 !!)
病例問題 – 病例內容
24
Note
就是「SOAP」中的S&O
25. } [參考答案 Answers]:
- Modifiable risk factors of this patient:
- Lifestyle: Smoking
- Medical: Hyperlipidemia, type II DM, HTN and Hx of
CAD
- Risk factors cannot be modified:
- Age
- Family Hx of CHD
一個重要待常被忽略掉的危險因子是「藥物」,藥師們應試
著篩選是否有藥物可能誘發或導致該疾病的可能性
病例問題 – 病例內容
25
Note
應包括可改變與不可改變的危險因子
26. } [問題 Questions]:
- Desired Outcome
- What is the immediate goal of therapy in this patient?
- How can this goal be achieved using
pharmacotherapy?
應避免空洞的目標: 治癒病人 (cure the patient)、緩解症
狀 (relieve the symptoms) 等
或過度窄化的目標: 醣化血色素 (HbA1c) <7%、血壓
(SBP/DBP) <135/80 mmHg
病例問題 – 病例內容
26
練習列出目前治療目標
針對該目標建議藥物治療
Note
27. } [參考答案 Answers]:
- The short-term goals of treatment for the ACS are:
- Early restoration of blood flow to the infarct-related
artery to prevent infarct expansion
- Prevention of death and other MI complications
- Prevention of coronary artery re-occlusion with re-
infarction
- Relief of ischemic chest discomfort
- Resolution of ST-segment and T-wave changes on
ECG
病例問題 – 病例內容
27
29. } [問題 Questions]:
- Therapeutic Alternatives
- What nonpharmacologic therapeutic alternative can
also achieve the immediate goal in this patient?
} [參考答案 Answers]:
- Initial therapy: oxygen (all patients for first 6 hours,
and then as needed to maintain SaO2 >90%)
- Immediate primary PCI: balloon angioplasty or
placement of a bare-metal or drug-eluting intra-
coronary stent)
病例問題 – 病例內容
29
30. } [問題 Questions]:
- Therapeutic Alternatives
- What is the role of adjunctive anticoagulant therapy
during PCI, and how should these therapies be
monitored?
} [參考答案 Answers]:
- Parenteral anticoagulants should be used to patients
undergoing PCI (ACCF/AHA Class I, Level C)
- Consider using enoxaparin at time of PCI in patients
who have not received prior antithrombin therapy
(ACCF/AHA Class IIb, Level B)
病例問題 – 病例內容
30
31. } [參考答案 Answers]:
- Monitor parameters of parenteral anticoagulants:
- Efficacy:
- Safety: S&S of bleeding (e.g. uncontrolled bleeding
from injection sites, hemoglobin drop of unknown
cause)
病例問題 – 病例內容
31
Anticoagulant Parameters
Unfractioned heparin (UFH) aPTT
Low-molecule weight heparin (LMWH) Anti-Xa
Fondaparinux Anti-Xa
Bivalirudin aPTT or ACT除了療效更應該有安全性指標
32. } [問題 Questions]:
- Therapeutic Alternatives
- What is the role of adjunctive antiplatelet therapy
before, during, and after PCI, and how should these
therapies be monitored?
} [參考答案 Answers]:
- Aspirin 162-325 mg should be given (chewed) on
first day of STEMI and continued indefinitely at 75-
162 mg once daily unless “true aspirin allergy”
(ACC/AHA Class I, Level A)
病例問題 – 病例內容
32
藥物治療建議常遺漏「療程」
33. } [參考答案 Answers]:
- Clopidogrel 75 mg orally once daily recommended in
addition to aspirin in patients with STEMI whether or
not they have reperfusion therapy (including
fibrinolytic therapy) (ACC/AHA Class I, Level A),
duration at least 14 days and up to 1 year
- Alternatives to clopidogrel include:
- Prasugrel (Effient) in patients having PCI
(ACCF/AHA Class I, Level B)
- Ticagrelor (Brilinta) 180 mg then 90 mg twice daily
(ACCF/AHA Class I, Level B)
病例問題 – 病例內容
33
34. } [問題 Questions]:
- Therapeutic Alternatives
- What are other important goals of therapy in this
patient?
} [參考答案 Answers]:
- The long-term goals following MI are to
- Control modifiable CHD risk factors
- Prevent the development of systolic HF
- Prevent recurrent MI and stroke
- Prevent death, including sudden cardiac death
病例問題 – 病例內容
34
35. } [問題 Questions]:
- Therapeutic Alternatives
- Based on the history and presentation, what initial
drug therapy is indicated in this patient?
} [參考答案 Answers]:
- The initial drug therapy of this patient would be:
- Aspirin 300 mg ST followed by 100 mg PO QD
- Clopidogrel 300 mg ST followed by 100 mg PO QD
- Enoxparin 1 mg/kg (a maximum dose of 100 mg is
recommended for the first 2 doses) SQ Q12H
病例問題 – 病例內容
35
36. } [參考答案 Answers]:
- Nitroglycerin 10 mcg/min IVF for persistent
discomfort due to ischemia, control of high blood
pressure, or treatment of pulmonary edema
- Carvedilol 12.5 mg PO BID
- Captopril 6.25 mg PO TID
- Atorvastatin 10 mg PO QD
- Metformin 500 mg PO BID (resume after PCI)
藥物治療應有詳盡的藥名、劑量、途徑、頻次,有特定使用
方式則說明
病例問題 – 病例內容
36
Note
37. } [問題 Questions]:
- Outcome Evaluation
- How should the recommended therapy be
monitored for efficacy and adverse effects?
} [參考答案 Answers]:
- Efficacy:
- Relief of ischemic discomfort
- Return of ECG changes to baseline
- Absence or resolution of HF signs
病例問題 – 病例內容
37
38. } [參考答案 Answers]:
- Adverse effects:
病例問題 – 病例內容
38
Drug Adverse effects Monitoring
Aspirin Dyspepsia,
bleeding, gastritis
Clinical signs of bleeding,
gastrointestinal upset;
baseline CBC and platelet
count; CBC platelet count
Q6M
Clopidogrel Bleeding, diarrhea,
rash, TTP (rare)
Same as aspirin
IV Nitrates Hypotension,
flushing, headache,
tachycardia
BP and HR Q2H
針對每一種藥物列出追蹤指標
有追蹤頻率將會更好
39. } [參考答案 Answers]:
病例問題 – 病例內容
39
Drug Adverse effects Monitoring
Enoxaparin Bleeding, heparin-
induced
thrombocytopenia
(HIT)
Clinical signs of bleeding;
baseline SCr, aPTT, INR,
CBC and platelet count;
daily CBC, daily CBC and
SCr
Carvedilol Hypotension,
bradycardia, heart
block, broncho-
spasm, acute heart
failure, fatigue
BP, HR, and clinical signs
of heart failure every shift
during oral administration
during hospitalization,
then BP and HR Q6M
following hospital
discharge
40. } [參考答案 Answers]:
病例問題 – 病例內容
40
Drug Adverse effects Monitoring
Captopril Hypotension,
cough, hyper-
kalemia,
prerenal
azotemia, acute
renal failure,
angioedema
BP Q2H x 3 for first dose,
then every shift during oral
administration during
hospitalization, then once
Q6M following hospital
discharge; baseline SCr and
K; daily SCr and K while
hospitalized
Atorvastatin GI upset,
myopathy,
hepatotoxicity
LFT at baseline, at 6 wks, and
after titration to highest dose,
then annually thereafter;
counsel patient on myalgia
42. } [問題 Questions]:
- Patient Education
- Based on his hospital course, which discharge
medications would be most appropriate for this
patient?
- What education should you provide to this patient?
} [參考答案 Answers]:
- For secondary prevention of myocardial infarction,
those are this patient needed…
病例問題 – 病例內容
42
43. } [參考答案 Answers]:
- To prevention LV remodeling following MI
- ACEIs, beta-blockers, and selective aldosterone
receptor antagonists have been shown to prevent it
and reduce mortality of these patients
病例問題 – 病例內容
43
44. } [參考答案 Answers]:
- Aspirin 100 mg PO QD indefinitely
- Clopidogrel 100 mg PO QD at least 1 month
- Carvedilol 12.5 mg PO BID
- Lisinopril 20 mg PO QD
- Atorvastatin 10 mg PO QD
- Metformin 1 gm PO BID
短期 (緩解心肌缺血症狀) 與長期 (預防再次心肌梗塞) 藥物
治療目標不同,應針對目標而有不同治療策略
病例問題 – 病例內容
44
Note
45. } [療程 Clinical Course]:
- Six months later, he states that he is really trying to
exercise more and eat better. He has been taking all
of his medications.
- He states there are some pain in his calves and
thighs, and he thinks at he has it is due to his
walking exercise
regimen he started 4 months ago.
- It is bothering him enough that he has had to stop
walking every day.
病例導讀 – 病例內容
45
46. } [療程 Clinical Course]:
- Labs reveal the following:
- TC 135 mg/dL TG 89 mg/dL HDL 39 mg/dL
LDL 78 mg/dL
- CK 450 IU/L
- Vitals: BP 130/80 mmHg and P 65 bpm.
} [後續問題 Follow-Up Question]:
- What is the cause of this patient's myopathy and
how should his regimen be modified taking into
consideration his adverse effects and his goal LDL?
病例導讀 – 病例內容
46